Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:

  • Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the 40th Annual Institutional Investors Conference in Orlando, FL, on Monday, March 4, 2019 at 3:25 PM (ET). The presentation, which will occur live at the JW Marriott Orlando Grande Lakes, will be concurrently webcast.

The link to the webcast will be available on the Dexcom website at by navigating to About Us, then Investor Relations, and finally Events and Presentations and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for use by people with diabetes and by healthcare providers.


Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

DexCom, Inc.
Steven R. Pacelli
Executive Vice
President, Strategy and Corporate Development
(858) 200-0200